Cell Based Assays Market Research Report 2024-2033: Key Drivers, Insights, Outlook, and Overview

Global cell based assays market size is expected to reach $41.86 Bn by 2028 at a rate of 11.7%, segmented as by product & service, consumables, instruments, services, software

Jul 15, 2024 - 13:24

Cell Based Assays Market Research Report 2024-2033: Key Drivers, Insights, Outlook, and Overview

Overview and Scope

Cell-based assays are experimental tools that are designed to study reactions taking place inside the cells. These assays are used to study a mechanism or process of cellular function.

Sizing and Forecast

The cell based assays market size has grown strongly in recent years. It will grow from $24.61 billion in 2023 to $26.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to emergence of hts techniques, integration of automation, utilization of biomarker detection, adoption of microfluidics, introduction of gene editing tools.

The cell based assays market size is expected to see rapid growth in the next few years. It will grow to $41.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to integration of ai and machine learning, shift in regulatory landscape, demand for high-content screening, advancements in disease modeling, focus on precision medicine. Major trends in the forecast period include high-throughput screening (hts), 3d cell cultures, organ-on-a-chip technology, crispr/cas9 technology, advancements in imaging techniques.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Segmentation & Regional Insights

The cell based assays market covered in this report is segmented –

1) By Product & Service: Consumables, Instruments, Services, Software

2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies

3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users

Sub-segements

By Instruments: Microplates, Microplate Readers, High Throughput Screening, Liquid Handling Systems

By Consumables: Reagents And Media, Cells And Cell Lines, Probes And Labels

North America was the largest region in the cell-based assays market in 2023. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp

Major Driver Impacting Market Growth

Research with cell-based arrays is increasing with evolution and there is a definite need to move to more predictive cellular models for drug discovery in order to control the last-stage drug failures. The pharmaceutical industries’ need to efficiently commercialize drugs in order to overcome expensive failures in the last stages is a driving force in cell-based assay innovation. Failure of investigational new drug (IND) Phase III clinical trials results in a loss of several hundred million dollars to that company. For instance, according to a report by Sigma, the return on investment for pharmaceutical companies could drop to 5% considering the current level of late-stage failures which is an unacceptable level for most companies. Major improvements to high-content systems and data analysis from the cell-based assays enable scientists to extract more information about the cellular response and help make informed decisions during drug discovery, and further driving the growth of the cell-based array market.

Key Industry Players

Major companies operating in the cell based assays market report are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam plc, BioVision Inc., Promega Corporation, Caliper Life Sciences Inc., Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation

The cell based assays market report table of contents includes: